Nonalcoholic Steatohepatitis (NASH) - Epidemiology Forecast To 2023
[Lowest Price Guaranteed: $2,750]

Published by Delve Insight: 31 May 2017 | 86071
Related Topics: Steatohepatitis

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Nonalcoholic
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email bioportfolio97@gmail.com.

Introduction

DelveInsight “Nonalcoholic Steatohepatitis (NASH) - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Nonalcoholic Steatohepatitis (NASH) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Nonalcoholic Steatohepatitis (NASH) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Nonalcoholic Steatohepatitis (NASH). The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope of the Report

• The Report includes the prevalent population and how will it change over the next eight years.

• Prevalent or incident cases segmented by age and sex.

• Coverage of key Nonalcoholic Steatohepatitis (NASH) subpopulations and its prevalent or incident cases

• The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Nonalcoholic Steatohepatitis (NASH) market.

• Identifying prevalent patient populations as well as risk factors in the global Nonalcoholic Steatohepatitis (NASH) market will help to improve product design, pricing, and launch plans.

• Organize sales and marketing efforts by identifying the best opportunities for Nonalcoholic Steatohepatitis (NASH) therapeutics in each of the markets covered.

Table of Contents
for Nonalcoholic Steatohepatitis (NASH) - Epidemiology Forecast To 2023

List Of Tables
in Nonalcoholic Steatohepatitis (NASH) - Epidemiology Forecast To 2023

Table 1: Clinical subtypes of Indication

Table 2: Risk Factors

Table 3: Prevalence cases (%) Region wise

Table 4: Sources used for forecasting the data

Table 5: Nonalcoholic Steatohepatitis (NASH) Global Epidemiology, (2013-2023)

Table 6: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), US (2013-2023)

Table 7: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), US (2013-2023)

Table 8: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population, US (2013-2023)

Table 9: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), United Kingdom (2013-2023)

Table 10: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), United Kingdom (2013-2023)

Table 11: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population, United Kingdom (2013-2023)

Table 12: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), Germany (2013-2023)

Table 13: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), Germany (2013-2023)

Table 14: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population, Germany (2013-2023)

Table 15: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), France (2013-2023)

Table 16: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), France (2013-2023)

Table 17: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population, France (2013-2023)

Table 18: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), Italy (2013-2023)

Table 19: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), Italy (2013-2023)

Table 20: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population, Italy (2013-2023)

Table 21: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), Spain (2013-2023)

Table 22: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), Spain (2013-2023)

Table 23: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population, Spain (2013-2023)

Table 24: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), Japan (2013-2023)

Table 25: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), Japan (2013-2023)

Table 26: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population, Japan (2013-2023)

List Of Figures, Charts and Diagrams
in Nonalcoholic Steatohepatitis (NASH) - Epidemiology Forecast To 2023

Figure 1: Prevalence cases (%) Region wise

Figure 2: Sources used for forecasting the data

Figure 3: Nonalcoholic Steatohepatitis (NASH) Global Epidemiology, (2013-2023)

Figure 4: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), US (2013-2023)

Figure 5: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), US (2013-2023)

Figure 6: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population,US (2013-2023)

Figure 7: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), United Kingdom (2013-2023)

Figure 8: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), United Kingdom (2013-2023)

Figure 9: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population,United Kingdom (2013-2023)

Figure 10: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), Germany (2013-2023)

Figure 11: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), Germany (2013-2023)

Figure 12: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population,Germany (2013-2023)

Figure 13: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), France (2013-2023)

Figure 14: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), France (2013-2023)

Figure 15: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population,France (2013-2023)

Figure 16: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), Italy (2013-2023)

Figure 17: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), Italy (2013-2023)

Figure 18: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population,Italy (2013-2023)

Figure 19: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), Spain (2013-2023)

Figure 20: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), Spain (2013-2023)

Figure 21: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population,Spain (2013-2023)

Figure 22: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) (Ages =XX Years), Japan (2013-2023)

Figure 23: Prevalent Cases of Nonalcoholic Steatohepatitis (NASH) By Sex (Males & Females), Japan (2013-2023)

Figure 24: Prevalent Cases By Nonalcoholic Steatohepatitis (NASH) Sub-population,Japan (2013-2023)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

86071 | DIEPR2017084

Number of Pages

40

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Nonalcoholic Steatohepatitis Therapeutics in Asia-Pacific Markets to 2024 - Launch of NASH-Specific Premium Products and Rising Prevalence to Drive the Market
Nonalcoholic Steatohepatitis Therapeutics in Asia-Pacific Markets to 2024 - Launch of NASH-Specific ...
03 Dec 2018 by GBI Research USD $4,995 More Info
Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast – 2027
"DelveInsight’s “Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Fore...
10 Jul 2017 by Delve Insight USD $5,750 More Info
Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Forecast-2023
Note*: This report requires 5-7 business days to complete.DelveInsight’s Nonalcoholic Steatohepatiti...
30 May 2017 by Delve Insight USD $4,950 More Info
Global Nonalcoholic Fatty Liver Disease Market Research Report Forecast 2017 to 2021
The Global Nonalcoholic Fatty Liver Disease Market Research Report Forecast 2017-2021 is a valuable ...
15 May 2017 by S&P Consulting USD $2,800 More Info
Nonalcoholic Drinks Market by Product Type (Soft Drinks, Bottled Water, Tea & Coffee, Juice, Dairy Drinks, and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Nonalcoholic drinks, also known as ‘virgin drinks’, ‘mocktails’ and ‘n...
20 Dec 2016 by Allied Market Research USD $5,370 More Info
Nonalcoholic Drinks Market by Product Type (Soft Drinks, Bottled Water, Tea & Coffee, Juice, Dairy Drinks, and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Nonalcoholic drinks, also known as ‘virgin drinks’, ‘mocktails’ and ‘near beer’, refer to the bevera...
01 Dec 2016 by Allied Market Research USD $4,740 More Info
Nonalcoholic Drinks Market by Product Type (Soft Drinks, Bottled Water, Tea & Coffee, Juice, Dairy Drinks, and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022
Nonalcoholic drinks, also known as ‘virgin drinks’, ‘mocktails’ and ‘near beer’, refer to the bevera...
01 Dec 2016 by Allied Market Research USD $5,370 More Info
Nonalcoholic Steatohepatitis (NASH): KOL Insight
IntroductionWho will benefit most from huge opportunities in NASH treatment?The first new NASH thera...
01 May 2016 by FirstWord Pharma USD $7,900 More Info
Nonalcoholic Steatohepatitis (NASH): KOL Insight
Who will benefit most from huge opportunities in NASH treatment?The first new NASH therapy is due so...
01 May 2016 by FirstWord Pharma USD $7,900 More Info
Nonalcoholic Steatohepatitis: KOL Insight
IntroductionWhy This Report is Essential Expect a revolution in the treatment of nonalcoholic steato...
01 Mar 2015 by FirstWord Pharma USD $7,900 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

We Stock...